Cargando…
Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356363/ https://www.ncbi.nlm.nih.gov/pubmed/37476339 http://dx.doi.org/10.1155/2023/9876715 |
| _version_ | 1785075254300770304 |
|---|---|
| author | and Alternative Medicine, Evidence-Based Complementary |
| author_facet | and Alternative Medicine, Evidence-Based Complementary |
| author_sort | and Alternative Medicine, Evidence-Based Complementary |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10356363 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103563632023-07-20 Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway and Alternative Medicine, Evidence-Based Complementary Evid Based Complement Alternat Med Retraction Hindawi 2023-07-12 /pmc/articles/PMC10356363/ /pubmed/37476339 http://dx.doi.org/10.1155/2023/9876715 Text en Copyright © 2023 Evidence-Based Complementary and Alternative Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction and Alternative Medicine, Evidence-Based Complementary Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway |
| title | Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway |
| title_full | Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway |
| title_fullStr | Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway |
| title_full_unstemmed | Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway |
| title_short | Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway |
| title_sort | retracted: nek2 serves as a novel biomarker and enhances the tumorigenicity of clear-cellrenal-cell carcinoma by activating wnt/β-catenin pathway |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356363/ https://www.ncbi.nlm.nih.gov/pubmed/37476339 http://dx.doi.org/10.1155/2023/9876715 |
| work_keys_str_mv | AT andalternativemedicineevidencebasedcomplementary retractednek2servesasanovelbiomarkerandenhancesthetumorigenicityofclearcellrenalcellcarcinomabyactivatingwntbcateninpathway |